Canadian MDx Firm Gets Investment from OGI
March 13, 2009
Canadian MDx Firm Gets Investment from OGI
The Ontario Genomics Institute has invested an undisclosed amount in Cytognomix, a London, Ontario-based developer of cytogenetic DNA probes for potential use in diagnostics.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Tech Transfer Tidbits
March 18, 2009 / - Ontario Genomics Institute Invests in New Cancer Dx Firm
March 9, 2012 / GenomeWeb Daily News - IP Watch: Sysmex, Quest, Genentech, Genetag Technologies, Roche, and Others Win US Patents
December 15, 2011 / PCR Insider - U of Toronto Team Wins CA$50K Grant to Develop Medical Genome Interpretation Software
November 16, 2011 / Clinical Sequencing News - NIDDK, NHLBI Seek Non-invasive Disease Tests
May 4, 2009 / GenomeWeb Daily News